PMID: 6986827Mar 1, 1980Paper

Azathioprine with prednisone for polymyositis. A controlled, clinical trial

Annals of Internal Medicine
T W BunchA G Engel

Abstract

A controlled, prospective, double-blind, therapeutic trial of azathioprine was conducted in the initial therapy of polymyositis. Sixteen patients received 60 mg prednisone per day plus either azathioprine (2 mg/kg of body weight per day) or placebo for a period of 3 months. Creatine phosphokinase (CPK) levels fell to normal slightly sooner in the placebo group, but not significantly so. The azathioprine group did not become significantly stronger (P = 0.58) and did not manifest significantly greater improvement of histopathologic features of muscle (P = 0.80) than the placebo group. Initial CPK elevations were significantly related to the degree of muscle inflammation (P = 0.037), but this was not the case at 3 months (P greater than 0.05). Normalization of the CPK could not be equated with disease control. Type II fiber atrophy, attributed to steroid therapy, was more marked in women than in men (P less than 0.03).

Citations

Nov 14, 2007·Zeitschrift für Rheumatologie·J Richter, C Iking-Konert
Nov 4, 2005·Clinical Rheumatology·Sandeep K AgarwalJonathan S Coblyn
Jul 30, 2008·Current Rheumatology Reports·Stephen J DiMartino
Aug 12, 2006·Current Rheumatology Reports·Steven R Ytterberg
Aug 5, 2003·Current Treatment Options in Neurology·Hannah R. Briemberg, Anthony A. Amato
Jan 12, 2011·Current Treatment Options in Neurology·B Jane DistadMichael D Weiss
Nov 30, 2000·Current Treatment Options in Neurology·F L MastagliaP J Zilko
Apr 1, 1988·Clinics in Dermatology·D L Tuffanelli, P E Lavoie
May 13, 1989·Lancet·J HeckmattV Dubowitz
May 25, 2013·Journal of Clinical Neuromuscular Disease·M NagappaT Yasha
Apr 1, 1994·International Journal of Dermatology·A S Boyd, K H Neldner
Oct 24, 2001·American Journal of Respiratory and Critical Care Medicine·W W DouglasJ H Ryu
Mar 17, 2010·Neurology India·J M K Murthy
Sep 27, 2003·Lancet·Marinos C Dalakas, Reinhard Hohlfeld
Jan 1, 2000·Lancet·J P Callen
Jul 16, 2010·Joint, Bone, Spine : Revue Du Rhumatisme·Anne TournadreMartin Soubrier
Jul 20, 2014·Neurologic Clinics·Mazen M DimachkieAnthony A Amato
Jan 1, 1995·Archives of Disease in Childhood·A Sansome, V Dubowitz
Jul 11, 2006·Postgraduate Medical Journal·A C Cordeiro, D A Isenberg
Oct 25, 2008·Arthritis Research & Therapy·Ingrid E Lundberg, Cecilia Grundtman
Nov 3, 2012·Seminars in Neurology·Mazen M Dimachkie, Richard J Barohn
Aug 28, 2015·Expert Review of Clinical Immunology·Siamak Moghadam-KiaChester V Oddis
May 2, 2009·Expert Opinion on Pharmacotherapy·Gerald J D HengstmanBaziel G M van Engelen
Jan 1, 1985·Drug Metabolism Reviews·K G Van ScoikW R Porter
Jan 16, 2016·Clinical Reviews in Allergy & Immunology·Siamak Moghadam-KiaRohit Aggarwal
Nov 26, 2010·Journal of Neuroimmunology·Mazen M Dimachkie
Nov 1, 2009·Reumatología clinica·Luís J CatoggioJavier E Rosa
Jan 12, 2005·Acta Clinica Belgica·P Cherin
Apr 1, 1993·Clinics in Dermatology·M R StonecipherJ L Jorizzo
Jul 18, 2015·Zeitschrift für Rheumatologie·K M Rösler, O Scheidegger
Jun 1, 2016·Frontiers in Neurology·Asma MalikMiguel A Guzman
Jul 17, 2016·Best Practice & Research. Clinical Rheumatology·Joanna TieuVidya Limaye
Jul 15, 2016·Nature Reviews. Rheumatology·Alain SarauxValérie Devauchelle-Pensec
Apr 29, 2010·Neuromuscular Disorders : NMD·J van de VlekkertUNKNOWN Dexa Myositis Trial
Jul 28, 2016·International Journal of Rheumatic Diseases·Ken-Ichi UenoShu-Ichi Ikeda
Jan 5, 2002·Neurologic Clinics·Amer AlshekhleeRobert L Ruff
Aug 1, 1997·Rheumatic Diseases Clinics of North America·L G Rider, F W Miller
Feb 9, 2000·Rheumatology·I Lundberg, Y Chung
Mar 30, 2018·Nature Reviews. Rheumatology·Chester V Oddis, Rohit Aggarwal
Apr 20, 2018·Modern Rheumatology·Hirokazu Sasaki, Hitoshi Kohsaka
Jun 20, 2001·Acta Physiologica Scandinavica·I E Lundberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.